These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3266 related items for PubMed ID: 22964144

  • 1. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J, Chen MH, Yang W, Wu W, Yan K.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768
    [Abstract] [Full Text] [Related]

  • 4. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO, Kim SK, Son BH, Yoo CH, Hong HP, Cho YK, Kim BI.
    Hepatobiliary Pancreat Dis Int; 2009 Dec 10; 8(6):591-6. PubMed ID: 20007075
    [Abstract] [Full Text] [Related]

  • 5. [Standard treatment of liver malignancies with radiofrequency ablation].
    Chen MH, Yang W, Yan K, Gao W, Dai Y, Wang YB, Huo L, Zhang H, Huang XF.
    Zhonghua Yi Xue Za Zhi; 2005 Jul 06; 85(25):1741-6. PubMed ID: 16253159
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Survival and prognostic analysis of radiofrequency ablation of hepatocellular carcinoma].
    Yang W, Chen MH, Gao W, Wu W, Huo L, Dai WD, Liu WY, Yan K.
    Zhonghua Wai Ke Za Zhi; 2006 Feb 01; 44(3):169-73. PubMed ID: 16635345
    [Abstract] [Full Text] [Related]

  • 9. [Long term (5 years) outcome of radiofrequency ablation for hepatocellular carcinoma in 256 cases].
    Chen MH, Yan K, Yang W, Gao W, Dai Y, Huo L, Zhang H, Huang XF.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec 18; 37(6):671-2. PubMed ID: 16378128
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma.
    Lencioni R, Della Pina C, Bartolozzi C.
    Abdom Imaging; 2005 Dec 18; 30(4):401-8. PubMed ID: 16132439
    [Abstract] [Full Text] [Related]

  • 13. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results.
    Peng ZW, Zhang YJ, Chen MS, Lin XJ, Liang HH, Shi M.
    Eur J Surg Oncol; 2010 Nov 18; 36(11):1054-60. PubMed ID: 20846819
    [Abstract] [Full Text] [Related]

  • 14. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
    Yang W, Chen MH, Yin SS, Yan K, Gao W, Wang YB, Huo L, Zhang XP, Xing BC.
    AJR Am J Roentgenol; 2006 May 18; 186(5 Suppl):S275-83. PubMed ID: 16632688
    [Abstract] [Full Text] [Related]

  • 15. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ.
    Am Surg; 2008 Jul 18; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [Abstract] [Full Text] [Related]

  • 16. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S.
    Oncology; 2007 Jul 18; 72 Suppl 1():98-103. PubMed ID: 18087189
    [Abstract] [Full Text] [Related]

  • 17. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
    Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH, Hwang YJ, Kim YI.
    Korean J Hepatol; 2005 Mar 18; 11(1):59-71. PubMed ID: 15788886
    [Abstract] [Full Text] [Related]

  • 18. [Clinical outcomes of radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: a single-center experience].
    Lin JJ, Wu W, Jiang XF, Jin XJ, Lu LJ, Bao LW.
    Zhonghua Zhong Liu Za Zhi; 2013 Feb 18; 35(2):144-7. PubMed ID: 23714672
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
    Liao GS, Yu CY, Shih ML, Chan DC, Liu YC, Yu JC, Chen TW, Hsieh CB.
    Eur J Surg Oncol; 2008 Jan 18; 34(1):61-6. PubMed ID: 17434711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 164.